Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa for Vision Improvement in Albinism
NCT01176435Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Sep 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa in Oculocutaneous albinism (OCA), sponsored by University of Minnesota. Started Sep 2010; status: completed.
02
Drugs
levodopa
03
Conditions
Oculocutaneous albinism (OCA)
Beyond the preview
Go deeper on NCT01176435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176435.